论文部分内容阅读
作者根据59例非T非B-ALL病人的血和骨髓细胞α-醋酸萘酚染色(ANAP)和酸性磷酸酶染色(AP)反应,将病人分为阳性组和阴性组,各组病人在不同医院按相同方案治疗,在缓解中位数为28月的随访后,对各组的高危例数、病人的性别、年龄、初诊时的白细胞计数进行统计学比较,无预后意义。AP~+和AP~-组CCR概率完全相同,ANAE~+组CCR概率低于ANAE~-组,但差异无显著性(P>0.05) 用抗-C-ALL血清检测出的39例病人,再按ANAP和AP阳性反应和阴性反应分组,对各组中的高危例数、性别、年龄、初诊时白细胞计数比较其复发率(X~2和MWU检验)。AP~+组6/13复发,AP~-组8/18复发。ANAE~+组7/9复发(死亡5例)。ANAE~-
The authors divided the patients into positive and negative groups according to the blood and bone marrow cells (ANAP) staining and acid phosphatase (AP) reaction in 59 non-T non-B-ALL patients. The hospitals were treated with the same protocol. After the median follow-up of 28 months, the number of high-risk patients in each group, the patient’s gender, age, and white blood cell count at the time of initial diagnosis were statistically compared. There was no prognostic significance. The probability of CCR in the AP~+ and AP~~ groups was exactly the same, and the CCR probability in the ANAE~+ group was lower than in the ANAE~~ group, but the difference was not statistically significant (P > 0.05). 39 patients were detected with anti-C-ALL serum. Then grouped by ANAP and AP positive reaction and negative reaction, the recurrence rate (X~2 and MWU test) was compared among the high-risk cases, gender, age, and white blood cell count at the initial diagnosis. The AP~+ group relapsed 6/13, and the AP~-group recurred 8/18. The recurrence was 7/9 in the ANAE+ group (five deaths). ANAE~-